Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application

Real-Time Quote  
Real-Time Quote Not Available Why not?
Real-Time Quote Only available during pre-market and regular market hours. about
  • Day Low  34.00 11:03 AM EST  
    Day High 34.62 09:52 AM EST
    Range 0.62  
    Volume 502,165  
    30-Day Avg Vol 760,000
    Difference -33.93%  
    Market Cap 2.26 B  
    Mkt Cap Chg -9.22 M  
    Shares Out 65.89 M  
    % Shrs Traded 0.76%  
    1yr EPS Est 2.243  
    52-Wk Low 19.92
    52-Wk High 40.14
    Range 20.22  
    Prev Close 34.53 11/5/09  
    Today's Open 34.18  
    Change -1.01%
    Dividend (TTM) 0.00  
    Div Yield (TTM) 0.00%
    Ex-Div Date
    Div Date
    Short Interest 3.27 M

    Performance Details

    Revenue (LFY) 1.34 B  
    Earnings (LFY) -521.84 M  
    Earnings (MRQ) 37.31 M  
    Next Earn Est 0.435  
    Next Earnings 02/08/2010
    EPS (TTM) -8.37  
    1yr EPS Growth -9.56%  
    P/E Ratio (TTM)  
    P/E Ratio (Fwd) 15.00  
    PEG Ratio 1.69  
    Return on Equity -36.48  
    Beta 1.17  
    Sector Healthcare  
    Industry Drugs  
    Click icons above for more info
  • Set and Manage Alerts

    Alert me if
  • Blog Posts: CRL

    Blogs are not currently available for crl.

    View all blogs at BloggingStocks.

  • Related Information: CRL

    Company Overview: CRL

    Charles River Laboratories International counts its chickens before they're hatched. The company provides clinical and laboratory research services and related products to pharmaceutical and biotech companies, ... View Full Description

    Earnings Analysis: CRL

    Analyst Consensus

    • Strong Buy
    • Buy
    • Hold
    • Sell
    • Strong Sell
    Earnings/Share(EPS) Estimate Actual Difference
    Next Quarter 0.435 2/8/10
    Last Quarter 0.602 9/30/09 0.65 9/30/09 0.048
    Beat
    2 Quarters Ago 0.582 6/30/09 0.66 6/30/09 0.078
    Beat

    Financials: CRL

      Quarterly - 09/26/2009 Annual - 2008
    Total Revenue 297.48 M 1.34 B
    Gross Profit 98.58 M 480.40 M
    Operating Income 44.45 M 250.24 M
    Net Income 37.31 M -521.84 M